Skip to main content

Day One Biopharmaceuticals, Inc.

DAWNDelisted Apr 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001845337

Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Day One Biopharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
130
−9 vs. Q2 2023
Shares held
77.5M
−1.25M (−1.6%) vs. Q2 2023
Total value
$951.5M
+$10.6M (+1.1%) vs. Q2 2023
New holders
13
56 more added
Sold out
22
35 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DAWN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 130 institutions
Q1 2021: 0 institutionsQ2 2021: 33 institutionsQ3 2021: 45 institutionsQ4 2021: 58 institutionsQ1 2022: 66 institutionsQ2 2022: 87 institutionsQ3 2022: 93 institutionsQ4 2022: 109 institutionsQ1 2023: 126 institutionsQ2 2023: 140 institutionsQ3 2023: 130 institutionsQ4 2023: 139 institutionsQ1 2024: 148 institutionsQ2 2024: 157 institutionsQ3 2024: 166 institutionsQ4 2024: 164 institutionsQ1 2025: 184 institutionsQ2 2025: 174 institutionsQ3 2025: 173 institutionsQ4 2025: 184 institutionsQ1 2026: 208 institutionsQ2 2026: 1 institution
Value heldQ3 2023: $951.5M
Q1 2021: $0Q2 2021: $401.1MQ3 2021: $452.9MQ4 2021: $698.3MQ1 2022: $429.6MQ2 2022: $1.06BQ3 2022: $1.21BQ4 2022: $1.29BQ1 2023: $818.1MQ2 2023: $941.0MQ3 2023: $951.5MQ4 2023: $1.12BQ1 2024: $1.20BQ2 2024: $1.03BQ3 2024: $1.28BQ4 2024: $1.19BQ1 2025: $747.1MQ2 2025: $561.1MQ3 2025: $603.5MQ4 2025: $758.4MQ1 2026: $1.85BQ2 2026: $3.55K
Institutions holding DAWN and their total value by quarter
QuarterHoldersValue
Q2 20261$3.55K
Q1 2026208$1.85B
Q4 2025184$758.4M
Q3 2025173$603.5M
Q2 2025174$561.1M
Q1 2025184$747.1M
Q4 2024164$1.19B
Q3 2024166$1.28B
Q2 2024157$1.03B
Q1 2024148$1.20B
Q4 2023139$1.12B
Q3 2023130$951.5M
Q2 2023140$941.0M
Q1 2023126$818.1M
Q4 2022109$1.29B
Q3 202293$1.21B
Q2 202287$1.06B
Q1 202266$429.6M
Q4 202158$698.3M
Q3 202145$452.9M
Q2 202133$401.1M
Q1 20210$0

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Day One Biopharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding DAWN in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Artal Group S.A.500,000$6.13M0.27%00.0%Unchanged
Sphera Funds Management Ltd.530,000$6.50M1.56%00.0%Unchanged
Point72 Asset Management, L.P.544,560$6.68M0.02%+413,560+315.7%Added
Verition Fund Management LLC548,757$6.73M0.09%+37,491+7.3%Added
Northern Trust Corp551,854$6.77M0.00%+119,262+27.6%Added
DAFNA Capital Management LLC586,463$7.20M2.24%+79,363+15.7%Added
Pictet Asset Management Holding SA600,039$7.36M0.01%+600,039New
Commodore Capital LP739,661$9.08M1.06%00.0%Unchanged
Janus Henderson Group PLC821,453$10.1M0.01%+133,943+19.5%Added
Baker Bros. Advisors LP1,000,000$12.3M0.07%00.0%Unchanged
Adage Capital Partners GP, L.L.C.1,036,599$12.7M0.03%−1,405,901−57.6%Reduced
TimesSquare Capital Management, LLC1,142,610$14.0M0.22%+336,910+41.8%Added
Boxer Capital, LLC1,189,943$14.6M0.78%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)1,269,992$15.6M0.34%00.0%Unchanged
Geode Capital Management, LLC1,293,114$15.9M0.00%+367,898+39.8%Added
Goldman Sachs Group Inc1,646,195$20.2M0.01%−746,328−31.2%Reduced
Polar Capital Holdings Plc1,935,000$23.7M0.18%+160,385+9.0%Added
Nicholas Investment Partners, LP2,188,654$26.9M2.01%−48,457−2.2%Reduced
PFM Health Sciences, LP2,224,598$27.3M1.31%+1,077,458+93.9%Added
Price T Rowe Associates Inc2,308,028$28.3M0.00%−1,703−0.1%Reduced
Canaan Partners XI LLC2,491,561$30.6M26.81%−56,842−2.2%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors2,558,563$31.4M0.13%00.0%Unchanged
State Street Corp2,935,919$36.0M0.00%−418,407−12.5%Reduced
Braidwell LP3,715,573$45.6M1.44%+353,760+10.5%Added
Franklin Resources Inc4,067,332$49.9M0.03%+1,6640.0%Added
Vanguard Group Inc4,629,754$56.8M0.00%+346,090+8.1%Added
BlackRock Inc.4,688,434$57.5M0.00%+1,123,701+31.5%Added
FMR LLC6,026,128$73.9M0.01%−1,533,775−20.3%Reduced
Atlas Venture Life Science Advisors, LLC7,608,394$93.4M14.46%00.0%Unchanged
Ra Capital Management, L.P.7,809,852$95.8M1.89%00.0%Unchanged
Logos Global Management LP0$00.00%−650,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−199,900−100.0%Sold out
Renaissance Technologies LLC0$00.00%−139,164−100.0%Sold out
CVI Holdings, LLC0$00.00%−80,000−100.0%Sold out
Jump Financial, LLC0$00.00%−70,031−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−54,000−100.0%Sold out
Bank of Montreal0$00.00%−37,895−100.0%Sold out
Davidson Kempner Capital Management LP0$00.00%−40,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−36,611−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−28,163−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−23,355−100.0%Sold out
XTX Topco Ltd0$00.00%−17,049−100.0%Sold out
Glenmede Trust Co NA0$00.00%−15,209−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−16,400−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−15,834−100.0%Sold out
AQR Capital Management LLC0$00.00%−14,404−100.0%Sold out
Nebula Research & Development LLC0$00.00%−12,380−100.0%Sold out
Laurion Capital Management LP0$00.00%−10,134−100.0%Sold out
Belvedere Trading LLC0$00.00%−5,945−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−3,530−100.0%Sold out
Leonteq Securities AG0$00.00%−700−100.0%Sold out
Simplex Trading, LLC0$00.00%−107−100.0%Sold out
PFS Investments Inc.––––Not filed